I think it's important to remember that this is an early stage company that has only completed a small FDA trial (equivalent to phase 1 in drug trials), which the market cap reflects. I'm not saying the share price can't increase, because it can, but IMO we are reasonably valued for a company that still needs to provide a concrete timeline to approval.
I'm here for the long haul so I have no problem being patient and I think it's very, very encouraging that we just raised $40 million essentially at the market with no options attached. That is a difficult feat for a speculative company to accomplish in these market conditions.
I think it's important to remember that this is an early stage...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |